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Abstract  
Withania somnifera (Family; Solanaceae) is commonly known as Ashwagandha and is used in traditionally system of 
medicine since long time. Many compounds have been reported from the root part of the plant. In present study, comparative 
evaluation of microbial consortium and uninoculated control plant root collected from different geographically sources was 
done by HPLC. Methanol soluble root extract of the plant was subjected to Column chromatography to isolate and purify the 
phyto-constituents which can be termed as markers. Three compounds were isolated and purified. Compounds were 
characterized as withanone and withaferin-A. The third compound was found to be impure. Novel HPLC methods were 
developed for assessment of purity, for standardization and for estimation of the compounds. Simplicity of isolation and 
HPLC analysis for the compounds suggests that the compounds may be termed as markers for the standardization of the 
methanol extracts and preparations containing Withania somnifera.  
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INTRODUCTION 
Withania somnifera, also known as Ashwagandha, Indian 
ginseng and winder cherry, has been an important herb in the 
Ayurvedic and indigenous medical systems for 3000 years. 
Historically, the plant has been used as an aphrodisiac, liver tonic, 
anti-inflammatory bronchitis, asthma, ulcers, emaciation, insomnia and 
senile dementia. Clinical trials and animal research support the use 
of Ashwagandha for anxiety, cognitive and neurological disorders, and 
inflammation and parakinsons disease. Ashwagandha chemopreventive 
properties make a potentially useful adjunct for patients undergoing 
radiation and chemotherapy.  
Ashwagandha is also used therapeutically as an adaptogen for 
patients with nervous exhaustion, insomnia and debility due to stress 
and as an immune stimulant in patients with low white blood cell 
counts. The major biochemical constituents of Ashwagandha root 
are steroidal alkaloids and steroidal lactones in a class of 
constituents called withaferin-A. For the preparation of methanol and 
aqueous extracts from root, stem and leaves conventional methods 
like sonication, refluxation, percolation and counter current 
extractions are used. Various Withaferin - A isolated from root parts 
of Withania somnifera have been analysed (Ganzora et al., 2003).  
Withaterin-A are present in roots, it is medicinally used. In the 
present investigation an attempt was made to isolate chemical 
constituents from the root of Withania somnifera and characterized 
them as markers and chemical comparison of them with the roots by 
HPLC (Dalavayis et al., 2006) fingerprinting. To improve the 
commercial outlook for the production of Withanterin-A, advanced 
chromatographic techniques were used. The present study helped in 
the isolation of Withanterin-A, from roots leaves and the yield 
chemical entities with that present in the root of Withania somnifera. 
MATERIALS AND METHODS 
Experimental  
Materials  
Standards Withaterin-A obtained from natural remedies Ltd. 
Veerasandra, Bangalore -100.  
Ashwangandha root sample  
Fresh root of Withernia somnifera (Ashwangandha) were 
collected in Department of Microbiology Garden Faculty of Agriculture, 
Annamalai University, Annamalainagar the collected root were dried 
at room temperature and then grounded into uniform powder. 
Solvent Methanol of A.R and HPLC grade purchased from E-merck 
for extraction and analysis.  
Preparation of standard and samples for HPLC analysis 
Standard  
10 mg of Withaterin-A working standard was dissolved in 50 ml 
of methanol (HPLC grade) which was further diluted by dissolving 1 
ml of this solution to 50 ml methanol.  
Sample preparation  
1 mg of the root samples were accurately weighed and dissolved 
in 50 ml of methanol HPLC grade. Further diluted 1 ml of this 
solution to 50 ml using methanol HPLC grade.  
Procedure 
20ml of standard and sample were injected to HPLC and record 
the chromatogram, calculated the content of Withaterin-A of the 
samples in comparison with standard.  
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Analytical method  
HPLC estimation of Withaterin-A performed on Shimdzu 10 AS 
HPLC system, equipped with UV detector. For estimation of 
Withatexin-A, Lichosorb C18 RP column (250×4.6 mm, μm particle 
size) and the mobile phase with mixture of acetonitrile: Methanol: 
ortho phosphoric acid (55:45:1)     
For peak confirmation as GC-MS experiment using an AQA 
mass spectrometer from finnigan together with a Finnigan HPLC (As 
3000 auto sampler, P4000 pump and UV5000 Lp detector) was 
performed. Best results were obtained in positive ES1 mode, with 
ionization voltage set to 50 V source voltage to 3.0 Kv and probe 
temperature to 350ºC with this instrumentation the separations had 
to be performed at ambient temperature. Thus in order to obtain 
similar retention times and good detection sensitivity the flow rate 
was reduced to 0.5 ml/min and the solvent gradient modified (55 A/ 
45 B to 45 A/ 55 B in  
25 min).  
Accuracy  
A recovery experiment was performed to confirm the accuracy of 
the method. Sample withaferin-A (1.0g) was spiked with 1.00 ml of 
the standard stock solution, and the extracted and analysed under 
optimized conditions. The recovery rates obtained were 97.59 % for 
1 and 100.0 % for 2. 
Ruggedness  
Intra and inter-day assay precision of the method was 
determined by analyzing five individual sample of one specimen 
(sample withaferin-A) on three consecutive days. The sample were 
extracted and assayed under optimized conditions; for detailed 
results see Table 2.  
RESULTS AND DISCUSSION  
The separation of three methanolic Withania somnifera extracts 
(root) under optimized conditions in shown in Fig 2. For 
corresponding structures see Fig. 1 Withaferin-A biologically active 
Withaferin-A which are also commercially available, where chosen 
as marker compounds of similar polarity in less than 25 min after all 
separation parameters were carefully. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemical structure of Withaferin -A  
 
Stationary phase of several manufacturers with different polarity 
(C-8, C-12, phenyl hexyl, particle size 3-5 µm) and column length 
(10-25cm) were initially screened for their applicability. A synergi 
C18 column (C-12 phase, 4µm particle size, 250×4.6 mm) from 
phenomenex showed the best results regarding peak symmetry and 
separation selectivity. The right mobile phase was crucial for a 
satisfactory result as well only by using methanol compound 
Withaferin-A could be well resolved from signal of the unidentified 
substance (a) (Fig. 1). In combination with reagent alcohol the 
separation was further improved, whereas the addition of acid, 
abutter or a modified (MBE, THF) to the mobile phase was not 
advantageous. Performing the separation time and the column 
backpressure, without any decrease in peak resolution.  
Additionally, an GC-MS experiment was performed to confirm the 
peaks of interest (Fig. 3). The HPLC conditions were slightly 
changed as the separation had to be performed at room temperature 
and flow rate of 1.0 ml compounds with modifications in the solvent 
composition and flow rate, the MS signals were readily assignable. In 
positive ESI mode, the spectra of 1 showed signals at m/2 of 488.3 
(M + N H4)+.  
The method was validated in accordance to USP determining 
several analytical and statistical parameters. Linearity of the detector 
response for the two standard compounds was confirmed between 
400.0 and 1.6 µg/ml, with a detection limit of at least 0.26 µg/ml (see 
Table 1 for the exact data). Peak purity and identify were verified by 
studying the PDA and MS data, as well as by spiking samples with 
reference compounds, no indications of impurities could be found. 
Accuracy of the method was confirmed by performing a recovery 
experiment. Sample Withaferin -A was spiked with a known amount 
of the authentic to the theoretical amount, recoveries off 97.59% for 
Withaferin-A were obtained. 
All standards and samples were injected in triplicate. The 
resulting R. S. D. of less than 2.0 % confirmed the precision of the 
method. Intra and inter-day variation of the assay was determined 
and showed to be lower than 5.0 % with a maximum R.S.D of 4.86 % 
reached at day 3 for compound Withaferin-A. The inter-day precision 
was better than 2.0 % for all compounds (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. HPLC Estimation of Withaferin - A from Withania somnifera plant root sample  
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Prior the analysis of Ashwagandha sample and products, the 
efficiency of the extraction procedure was verified. Thus one sample 
Withaferin-A was repeatedly extracted with 3 ml of the methanol and 
extract analyzed separately. Compounds Withaferin-A were not 
detectable after the fifth repetition of the procedure. A minimum of 
97.8 % of the compounds toes in solution after a 3 fold extraction, 
therefore, this was already considered as an exhaustive procedure. 
The analysis of Withania somnifera microbial consortium and 
uninoculated control plant root confirmed the presence of Withaferin-
A in root parts, of the plant, but with significant differences in their 
ratio (Table 3). This compound was only minor in uninocualted 
control plant root were a consortium rather high amount of 
Withaferin-A was found (0.238 %). Single and Double inoculated 
contained the lowest percentage of total Withaterin-A 1 and 2 
(0.055 %). Finally six market products (capsules, tablets and liquid 
extract containing Withenia somnifera) were analyzed. In all of these, 
even in multi component preparations. The one marker compounds 
were assignable pot all of the samples followed the previously 
described pattern with Withaferin-A being in roots. The higher 
percentages of Withaferin-A samples. A different extract procedure 
applied by the manufacturer of chemo types of the plant (which have 
been reported in the literature (11, 14)). The content of Withaferin-A 
in solid samples varied from 0.009 % to 0.100% comparing the total 
daily uptake, based on the manufactures suggestions, permits a 
better estimation at the overall product quality. As it is evident from 
Table 3, values from 0.06 to 2.57 µg/day were obtained which is 
nearly a 4 – fold variation. 
 
 
 
 
 
 
 
 
 
 
 
GC-MS chromatogram of Withania somnifera root samples 
 
 
Table 1: Correlation coefficient (R2), regression equation and limit of detection (LoD) for compound Withaferin-A 
Compound R2 Regression equation LoD (µg/ml) 
Withaferin -A 0.9996 Y=1.25×104× 0.26 
 
Table 2: Intra and inter day precision of sample Withaferin-A  assayed under optimized conditions 
Compound Intra – day* Inter – day** Day 1 Day 2 Day 3 
Withaferin – A 353.81 
(4.74) 
358.96  
(2.85) 
346.54  
(4.86) 
353.10 (1.76) 
 Samples in µg/g; R.S.D’s are given in parentheses; * (n=5); ** (n=3) 
 
Table 3: Percentage of withanolides in different Withania somnifera samples 
Sample Description 1 2 1-2 § 
W.S. 1 Single inoculation  (Azospirillum) 0.035 (1.04)* 0.019 (1.61)* 2.51 
W.S. 1 Double inoculation  
(Azospirillum, Pseudomonas fluorescence) 
0.027 (1.04)** 0.238 (1.52)** 1.32 
W.S. 1 Consortium  
(Azospirillum, Azotobacter, Pseudomonas fluorescence 
and Bacillus) 
0.065 (1.02)** 0.364 (1.06)** 2.57 
W.S. 1 Control plant  0.066 (1.91)* 0.193 (1.96)* - 
*Values in g/100g; ** Values in mg/ml; n=3, R.S.D. s are given in parentheses; §, daily uptake of withanolides in commercial samples (mg/day). 
 
CONCLUSION  
In conclusion, the method described herein represents a 
significant improvement in the analysis of alkaloid in Withania 
somnifera. In not only allows the direct, rapid and accurate 
determination of withaferin-A in plant material but it also fulfills all 
criteria of a validated method. Thus it should be helpful for scientific 
as well as commercial applications. 
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